MYO
MYOMO (MYO)
NYSE
$1.20-$0.05 (-4.40%)
Price as of Jun 23, 2026 7:14 PM EDT
  • $48.3M
    Market Cap
  • -44.93%
    1-Year Change
  • Medical Devices
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 52
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$1.25
$1.41
$1.25
1-Year Range
$0.64
$2.36
$1.25
Latest Close$1.25
Change
-$0.03 (-2.40%)
Volume801,092
Market Cap$48.3M
Shares Outstanding38.6M
P/E (TTM)-3.48
Diluted EPS (TTM)-$0.36
Enterprise Value$50.6M

Information as of 06/22/2026

Company Profile

$48.3M
Market Cap
-$15.1M
Net Income
Sector: Healthcare
Industry: Medical Devices
45 Blue Sky Dr., Burlington, MA, United States, 01803
617 996 9058

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.

Key Executives

  • Paul R. Gudonis
  • David A. Henry
  • Harry Kovelman
  • Micah J. Mitchell
  • Colin Anderson

Current Ownership Distribution

  • Institutions152.2M (82.71%)
  • Mutual Funds25.7M (13.98%)
  • Insiders6.1M (3.31%)
  • Other0 (0.00%)